Global Ceramic Inks Market Growth, Demand, Rising Trends and Forecast to 2025Posted by rekha on October 23rd, 2019 The global molecular diagnostics market is expected to reach US$ 11.87 Bn by 2025. The global molecular diagnostics market is driven by technological advancements in the molecular diagnostics field which allowed greater precision, transportability, and cost-effectiveness. Molecular diagnostics play a vital part in infectious disease testing as they offer effective and quick results. Additionally, rising incidence of infectious diseases and hospital-acquired infections is expected to boost the global molecular diagnostics market over the coming years. Intensification in the finance by the governments and different organizations for clinical studies in the molecular diagnosis field are also anticipated to drive the growth of global molecular diagnostics market. On the contrary, regulatory framework belong to approval process has constantly remained the utmost critical factor preventive the biotechnological, pharmaceutical, and medical technology markets growth. Furthermore, absence of a robust compensation background for personalized and genomic medicine is likely to detain the global molecular diagnostics market growth in near future. Global molecular diagnostics market is segmented on the basis of product type, technology, application, end user, and region. Request for sample report @ https://www.precisionbusinessinsights.com/request-sample?product_id=16755 Polymerase Chain Reaction (PCR)Dominate the Global Molecular Diagnostics Market Based on the technology, global molecular diagnostics market is segmented into isothermal nucleic acid amplification, hybridization, polymerase chain reaction (PCR), microarray, next-generation sequencing, and others. PCR is the most commonly used technology in the field of molecular diagnostics. Augmented practice and technological advancements in PCR techniques, such as multiplex PCR is expected to propel the growth of this segment in the forecast period.
North America Leads the Global Molecular Diagnostics Market PBI’s global molecular diagnostics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global molecular diagnostics market through 2014-2018 and expected to dominate over 2019-202 owing to the presence of the major market key players and well-established diagnostic organization. Moreover, technological advancements coupled with the patient’s awareness is surging the growth of molecular diagnostics market in North American region. Additionally, increasing occurrence of infectious diseases and hospital-acquired infections are also propelling the molecular diagnostics market growth. For instance, according to World Health Organization, in 2019, the average prevalence rate of hospital-acquired infections in USA was 4.5%. Europe molecular diagnostics market shows a significant share in the global molecular diagnostics market due to the increasing prevalence to hospital-acquired infections. For example, in 2019, the average prevalence rate of hospital-acquired infections in European region is 7.1 % (according to World Health Organization). Furthermore, technological advancement and high disposable income is also boosting the molecular diagnostics market in the region. The molecular diagnostics market of Asia Pacific is expected to grow in the forecast period owing to the huge population pool, improved diagnosis demand, and emerging economies. Additionaly, growing government’s initiatives in countries, such as China and India, to progress the healthcare infrastructure are estimated to fuel the molecular diagnostics market growth in APAC region. Launch of newer products, product approvals, and strategic alliances are the key strategies adopted by market players
Global molecular diagnostics market further reveals that the key player’s increasingly adopting strategies such as product approvals and launches, collaborations and long term alliance to expand the market revenue share and to gain noteworthy geographic presence across the region.
Key player’s profiles in the report are Cepheid Inc. (Danaher Corporation) (USA), Biomerieux (Sofiana s.a.) (France), Beckman Coulter, Inc. (Danaher Corporation) (USA), Becton, Dickinson and Company (USA), Siemens Healthcare GmbH (Germany), Abbott Laboratories (USA), Grifols (Spain), Hologic, Inc. (USA), Qiagen (USA), Meridian Bioscience (USA), Alere Inc. (USA), Roche Diagnostics (USA), and DiaSorin S.p.A. (American Standard Companies) (Italy). Precision Business Insights (PBI) in its report titled “Global Molecular Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Detailed Segmentation
By Product Type
By Technology
By Application
By End User
Geography
o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)
For more information: https://www.precisionbusinessinsights.com/market-reports/global-molecular-diagnostics-market/ Like it? Share it! More by this author |